IDH1 and central nervous system cancer: For instance, IDH1 mutation has been shown to reduce leukocyte chemotaxis into gliomas in a syngenic mouse model by repressing the expression of key chemoattractant cytokine genes, including Cxcl-2, Ccl-2 and C5 [107].